Back to School: How biopharma can reboot drug development. Access exclusive analysis here

RSD1235: COM completed dosing in a placebo-controlled North American Phase II trial of RSD1235.

Cardiome Pharma Corp. (TSE:COM; COMRF), Vancouver,

Read the full 61 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE